Compounds of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula 1, A1 and A2 are each an aromatic ring, a 5-6-membered heterocyclic ring, an aromatic ring fused to a heterocyclic ring, a phenyl ring fused to a heterocyclic ring, or a cycloalkyl ring.

一种稠合三环γ-氨基酸衍生物的制备方法及中间体，和制备该稠合三环γ-氨基酸衍生物的中间体的方法。所述稠合三环γ-氨基酸衍生物具有式（Ⅰ）所示的结构。所述制备方法原料易得、步骤简单，整个合成工艺都用结晶纯化，没有用到硅胶柱层析或其他制备色谱方法，适宜大规模工业化生产。

提供联苯化合物的制备及应用。以2-硝基芳基乙烯及取代的1，3-丁二烯为原料一步得到2-氨基联苯化合物、2-硝基联苯化合物或它们的混合物；反应得到的2-硝基联苯化合物或其与2-氨基联苯化合物的混合物可还原制备2-氨基联苯化合物。以该方法制备的2-氨基联苯化合物为原料与酰氯反应可制得具有杀菌作用的酰胺化合物。该方法避免使用金属化合物、贵金属催化剂及特殊硼试剂，以简单易得化合物原料一步得到联苯化合物，工艺步骤少，后处理简单，利于工业化。

Glycine is an organic compound that can be used in the making of a synthetic acid that obviates all the drawbacks of strong acids such as hydrochloric acid. The new compound is made by dissolving glycine in water, in a weight ratio of approximately 1:1 to 1:1.5. The solution is mixed until the glycine is essentially fully dissolved in the water. Once dissolution is complete, hydrogen chloride gas is dissolved in the solution to produce the new compound, which can be referred to as hydrogen glycine.

　透光性基体上に１層積層した構成で、防眩機能、高コントラスト化、色再現性、ギラツキ防止をバランスよく満足することのできる光学フィルムを提供する。本発明の光学フィルムは、透光性基体上に、透光性樹脂微粒子と放射線硬化型樹脂組成物とを含有した樹脂層を積層し、ヘイズ値が４０～６０％、０．５ｍｍ幅の光学くしを用いた透過像鮮明度が５～３５％であり、樹脂層の最表面の平均傾斜角度が０．８～３．０度の微細な凹凸形状を有することを特徴とする。